2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1396946604 M.D.
Verify on CMS →

LOURDES LAGONOWICZ, M.D.

Endocrinology, Diabetes & Metabolism Physician in MIAMI, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 276 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
46%
generic claims · 54% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

LOURDES LAGONOWICZ, M.D. filed 1,011 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in MIAMI, Florida, prescribing 46% generic.

1K
Part D claims, 2023
46%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LOURDES LAGONOWICZ, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,011 Top 24% higher than 76% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). This entry sits in this band. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

LOURDES LAGONOWICZ, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LOURDES LAGONOWICZ, M.D.?

Quality data not reported

NPI registry status

Active

Issued 05/31/2007

NPI 1396946604

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

1,011 62% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Florida

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers

Florida providers

Endocrinology, Diabetes & Metabolism Physician share within Florida

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LOURDES LAGONOWICZ, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 1450 NW 10TH AVE, MIAMI, FL, 33136, with a listed phone of (305) 243-3636. NPI 1396946604 was issued on 05/31/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LAGONOWICZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,011 prescription claims written by this provider, covering 276 Medicare beneficiaries and totaling roughly $247K in drug spend, split 54% brand-name and 46% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1450 NW 10TH AVE
MIAMI, FL 33136

Provider Details

NPI 1396946604
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Female
NPI Issued 05/31/2007

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to LOURDES LAGONOWICZ, M.D.. To verify LOURDES LAGONOWICZ, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

LOURDES LAGONOWICZ, M.D. — brand share 54.0%
Specialty average (est.)

54% brand-name claims vs 46% generic, on 1,011 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,011
Total Claims
$247K
Total Drug Cost
276
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,638
Total Day Supply
48,113
Brand vs Generic
54% brand / 46% generic
Brand Drug Cost
$241K
Generic Drug Cost
$5K

Patient Demographics

Average Patient Age
75.0 years
Avg HCC Risk Score
1.74
Gender Split
59% female / 41% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LOURDES LAGONOWICZ, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Jardiance
Empagliflozin
82
Levothyroxine Sodium
71
Testosterone
64
Metformin Hcl
57
Pioglitazone Hcl
54
Synthroid
Levothyroxine Sodium
54
Trulicity
Dulaglutide
46
Vitamin D2
Ergocalciferol (Vitamin D2)
46
Glipizide
45
Semglee (Yfgn) Pen
Insulin Glargine-Yfgn
39

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How LOURDES LAGONOWICZ, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

LOURDES LAGONOWICZ, M.D.'s 1,011 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as LAGONOWICZ.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LOURDES LAGONOWICZ, M.D.'s specialty?
LOURDES LAGONOWICZ, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in MIAMI, Florida. Credentials: M.D..
How much does LOURDES LAGONOWICZ, M.D. prescribe under Medicare Part D?
In 2023, LOURDES LAGONOWICZ, M.D. wrote 1,011 Medicare Part D claims totaling $247K in drug costs for 276 beneficiaries.
Where is LOURDES LAGONOWICZ, M.D. located?
LOURDES LAGONOWICZ, M.D. is located at 1450 NW 10TH AVE, MIAMI, FL, 33136. Phone: (305) 243-3636.
What is LOURDES LAGONOWICZ, M.D.'s NPI number?
LOURDES LAGONOWICZ, M.D.'s National Provider Identifier (NPI) is 1396946604, issued on 05/31/2007.
Does LOURDES LAGONOWICZ, M.D. prescribe more brand-name or generic drugs?
LOURDES LAGONOWICZ, M.D.'s prescribing is 54% brand-name and 46% generic drugs by claim count, with $241K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does LOURDES LAGONOWICZ, M.D. prescribe most often?
Based on 2023 Medicare Part D data, LOURDES LAGONOWICZ, M.D.'s most frequently prescribed drugs include Jardiance, Levothyroxine Sodium, Testosterone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LOURDES LAGONOWICZ, M.D. accept Medicare?
LOURDES LAGONOWICZ, M.D. appears in CMS Medicare data with 1,011 Part D claims and 276 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LOURDES LAGONOWICZ, M.D.'s credentials?
LOURDES LAGONOWICZ, M.D.'s NPI is 1396946604 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology